• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Occlusion (1984)
Event Date 11/18/2020
Event Type  Injury  
Manufacturer Narrative
Initial reporter facility name: (b)(6).
 
Event Description
It was reported that in-stent occlusion occurred.The subject was enrolled in the (b)(6) study on (b)(6) 2018 and the index procedure was performed on the same day.The target lesion was located in the left distal superficial femoral artery (sfa) with 90% stenosis and was 30 mm long with a proximal reference vessel diameter of 5 mm and a distal reference vessel diameter of 5 mm and was classified as tasc ii a lesion.The target lesion was treated with direct placement of a 6 mm x 40 mm study stent.Following post dilation, the residual stenosis was 0%.On (b)(6)2018, the subject was discharged on aspirin and clopidogrel.On (b)(6) 2020, the subject visited the site for protocol scheduled 24-month follow-up visit.(b)(6) classification assessed on (b)(6) 2020 was 0 (asymptomatic) and the ankle brachial index (abi) ratio was 1.Duplex ultrasound performed on (b)(6) 2020 revealed high grade in-stent occlusion of the left sfa.No action was taken to treat the event.Event was considered not recovered/ not resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10927641
MDR Text Key218938165
Report Number2134265-2020-16699
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/27/2019
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0022272708
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/31/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
-
-